Journal
GENES
Volume 10, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/genes10100736
Keywords
fine needle aspiration; cytology; thyroid cancers; molecular testing; personalized medicine
Categories
Funding
- Elizabeth and Michael Ruane Center for Endocrine Tumors Fund
Ask authors/readers for more resources
Thyroid nodules are common in the adult population where a majority are benign and only 4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early stages to evaluate and triage patients with thyroid nodules. While a definitive cytological diagnosis is provided in more than 70-75% of all thyroid FNA cases, the group of indeterminate lesions offers a challenge in terms of interpretation and clinical management. Molecular testing platforms have been developed, are recognized as an option by the 2015 American Thyroid Association Guidelines, and are frequently used in conjunction with FNA as an integral part of the cytologic evaluation. In this review, the utility of molecular testing options for nodules assigned to the group of indeterminate thyroid FNAs is described.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available